tyrosine kinase inhibitor

(redirected from Protein kinase inhibitor)
Also found in: Dictionary, Thesaurus, Wikipedia.
Related to Protein kinase inhibitor: Gleevec, Sorafenib, Sunitinib, Jakafi, Votrient

tyrosine kinase inhibitor

n.
Any of a class of drugs, such as imatinib, that target and block the action of specific tyrosine kinases and are used especially in the treatment of chronic myelogenous leukemia and other cancers.
References in periodicals archive ?
Other examples of protein kinase inhibitors are imatinib, a tyrosine-kinase inhibitor (TKI) marketed by Novartis as Gleevec for chronic myeloid leukemia and gastrointestinal stromal tumors (GISTs), and sunitinib, marketed by Pfizer as Sutent for GISTs, advanced kidney cancer, and pancreatic neuroendocrine tumors, noted Dr.
Pipeline drugs include protein kinase inhibitors, monoclonal antibodies and vaccines, with a total of 1,198 molecules under investigation.
Founded in 2001, AB Science is a pharmaceutical company specializing in the research, development and commercialization of protein kinase inhibitors (PKIs), a new class of targeted molecules whose action is to modify signaling pathways within cells.
Total quantity or scope: The contract is a continuous supply of medicines containing protein kinase inhibitors (hereinafter medicines or LP) for 2 years according to the current needs of the client.
This triple analysis focuses on cancer drug development strategies in Lung Cancer and by the two mechanism/target/effect areas of Apoptosis and Protein Kinase Inhibitors.
PARIS -- AB Science SA (Paris:AB)(NYSE-Euronext-FR0010557264-AB), a pharmaceutical company specializing in the research, development and commercialization of protein kinase inhibitors, announces the publication of results from the human phase 2 study of masitinib carried-out in the treatment of progressive multiple sclerosis.
com/research/pjcf9l/triple_analysis_c) has announced the addition of the "Triple Analysis: Cancer Vaccines, Protein Kinase Inhibitors and Peptides" report to their offering.
This triple analysis focuses on cancer drug development strategies in Pancreatic Cancer and by the two mechanism/target/effect areas of Cancer Vaccines and Protein Kinase Inhibitors.
com/research/83g48s/triple_analysis_p) has announced the addition of the "Triple Analysis: Pancreatic Cancer, Protein Kinase Inhibitors and Peptides" report to their offering.
This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Lung Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors.
com/research/8e764a/triple_analysis_l) has announced the addition of the "Triple Analysis: Leukemia, Protein Kinase Inhibitors and Peptides" report to their offering.
com/research/e8f905/triple_analysis_l) has announced the addition of the "Triple Analysis: Leukemia, Protein Kinase Inhibitors and Antibodies" report to their offering.

Full browser ?